Ubs Group Ag Century Therapeutics, Inc. Put Options Transaction History
Ubs Group Ag
- $555 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IPSC
# of Institutions
66Shares Held
23.8MCall Options Held
33.4KPut Options Held
0-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$3.08 Million0.91% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$1.65 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.11MShares$1.2 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.02MShares$1.15 Million0.0% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA1.7MShares$971,4120.28% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $33.6M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...